<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK541503" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK541503/" /><meta name="ncbi_pagename" content="FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/05/23" /><meta name="citation_author" content="Cecilia Giunta" /><meta name="citation_author" content="Marianne Rohrbach" /><meta name="citation_author" content="Christine Fauth" /><meta name="citation_author" content="Matthias Baumann" /><meta name="citation_pmid" content="31132235" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK541503/" /><meta name="citation_keywords" content="kEDS-FKBP14" /><meta name="citation_keywords" content="kEDS-FKBP14" /><meta name="citation_keywords" content="Peptidyl-prolyl cis-trans isomerase FKBP14" /><meta name="citation_keywords" content="FKBP14" /><meta name="citation_keywords" content="FKBP14-Kyphoscoliotic Ehlers-Danlos Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Cecilia Giunta" /><meta name="DC.Contributor" content="Marianne Rohrbach" /><meta name="DC.Contributor" content="Christine Fauth" /><meta name="DC.Contributor" content="Matthias Baumann" /><meta name="DC.Date" content="2019/05/23" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK541503/" /><meta name="description" content="FKBP14 kyphoscoliotic Ehlers-Danlos syndrome (FKBP14-kEDS) is characterized by congenital muscle hypotonia and weakness (typically improving during childhood), progressive scoliosis, joint hypermobility, hyperelastic skin, gross motor developmental delay, myopathy, and hearing impairment. Most affected children achieve independent walking between ages two and four years. A decline of motor function in adulthood may be seen, but affected individuals are likely to be able to participate in activities of daily living in adulthood and maintain independent walking. Occasional features underlying systemic connective tissue involvement include aortic rupture and arterial dissection, subdural hygroma, insufficiency of cardiac valves, bluish sclerae, bladder diverticula, inguinal or umbilical herniae, and premature rupture of membranes during pregnancy. Rarer findings may include bifid uvula with submucous or frank cleft palate, speech/language delay without true cognitive impairment, and rectal prolapse." /><meta name="og:title" content="FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="FKBP14 kyphoscoliotic Ehlers-Danlos syndrome (FKBP14-kEDS) is characterized by congenital muscle hypotonia and weakness (typically improving during childhood), progressive scoliosis, joint hypermobility, hyperelastic skin, gross motor developmental delay, myopathy, and hearing impairment. Most affected children achieve independent walking between ages two and four years. A decline of motor function in adulthood may be seen, but affected individuals are likely to be able to participate in activities of daily living in adulthood and maintain independent walking. Occasional features underlying systemic connective tissue involvement include aortic rupture and arterial dissection, subdural hygroma, insufficiency of cardiac valves, bluish sclerae, bladder diverticula, inguinal or umbilical herniae, and premature rupture of membranes during pregnancy. Rarer findings may include bifid uvula with submucous or frank cleft palate, speech/language delay without true cognitive impairment, and rectal prolapse." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK541503/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/fkbp14-keds/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK541503/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D7293E0404AD1000000000653022C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK541503_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK541503_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/craniosynostosis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/x-pvh/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK541503_"><span class="title" itemprop="name"><i>FKBP14</i> Kyphoscoliotic Ehlers-Danlos Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: kEDS-<i>FKBP14</i></div><p class="contrib-group"><span itemprop="author">Cecilia Giunta</span>, PhD, <span itemprop="author">Marianne Rohrbach</span>, MD, PhD, <span itemprop="author">Christine Fauth</span>, MD, and <span itemprop="author">Matthias Baumann</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK541503_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK541503_ai__"><div class="contrib half_rhythm"><span itemprop="author">Cecilia Giunta</span>, PhD<div class="affiliation small">Division of Metabolism and Children&#x02019;s Research Center<br />University Children's Hospital<br />Zurich, Switzerland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="hc.hzu.ipsik@atnuig.ailicec" class="oemail">hc.hzu.ipsik@atnuig.ailicec</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Marianne Rohrbach</span>, MD, PhD<div class="affiliation small">Division of Metabolism and Children&#x02019;s Research Center<br />University Children's Hospital<br />Zurich, Switzerland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="hc.hzu.ipsik@hcabrhor.ennairam" class="oemail">hc.hzu.ipsik@hcabrhor.ennairam</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Christine Fauth</span>, MD<div class="affiliation small">Division of Human Genetics<br />Medical University of Innsbruck<br />Innsbruck, Austria<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ta.ca.dem-i@htuaf.enitsirhc" class="oemail">ta.ca.dem-i@htuaf.enitsirhc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Matthias Baumann</span>, MD<div class="affiliation small">Department of Pediatrics I<br />Pediatric Neurology<br />Medical University of Innsbruck<br />Innsbruck, Austria<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ta.nekinilk-lorit@nnamuab.saihttam" class="oemail">ta.nekinilk-lorit@nnamuab.saihttam</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 23, 2019</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="fkbp14-keds.Summary" itemprop="description"><h2 id="_fkbp14-keds_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>FKBP14</i> kyphoscoliotic Ehlers-Danlos syndrome (<i>FKBP14</i>-kEDS) is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscle hypotonia and weakness (typically improving during childhood), progressive scoliosis, joint hypermobility, hyperelastic skin, gross motor developmental delay, myopathy, and hearing impairment. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children achieve independent walking between ages two and four years. A decline of motor function in adulthood may be seen, but affected individuals are likely to be able to participate in activities of daily living in adulthood and maintain independent walking. Occasional features underlying systemic connective tissue involvement include aortic rupture and arterial dissection, subdural hygroma, insufficiency of cardiac valves, bluish sclerae, bladder diverticula, inguinal or umbilical herniae, and premature rupture of membranes during pregnancy. Rarer findings may include bifid uvula with submucous or frank cleft palate, speech/language delay without true cognitive impairment, and rectal prolapse.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Clinical diagnostic criteria rely on the finding of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular hypotonia AND congenital or early-onset kyphoscoliosis in addition to generalized joint hypermobility or further <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-specific and/or supportive clinical features. The diagnosis of <i>FKBP14</i>-kEDS is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FKBP14</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> In those with aortic dilation or vascular dissection, use of beta blockers may be considered; physical and occupational therapy to address age-dependent decline in muscular strength; standard treatment for severe scoliosis, clubbed foot, osteopenia/osteoporosis, refractive error, hearing impairment, and cleft palate.</p><p><i>Surveillance:</i> Blood pressure measurement at each visit; neurodevelopmental assessment at each visit until adolescence; evaluation by an orthopedic physician as clinically indicated but typically at least annually; periodic ophthalmology and hearing evaluations (e.g., every 2-3 years); DEXA scan, echocardiogram with consideration of cardiac MRI, and vascular ultrasonography every 2-5 years.</p><p><i>Agents/circumstances to avoid</i>: Sports that place stress on the joints; contact sports in those with an aortic aneurysm; hypertension.</p><p><i>Pregnancy management</i>: An increased risk for miscarriage, premature rupture of membranes, and rupture of arteries in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> pregnant women should be considered. Delivery in a medical center with a high-risk perinatologist in attendance is recommended.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>FKBP14</i>-kEDS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for a pregnancy at increased risk are possible if both <i>FKBP14</i> pathogenic variants have been identified in a family.</p></div></div><div id="fkbp14-keds.Diagnosis"><h2 id="_fkbp14-keds_Diagnosis_">Diagnosis</h2><p>Formal clinical diagnostic criteria for <i>FKBP14</i> Kyphoscoliotic Ehlers-Danlos syndrome (<i>FKBP14</i>-kEDS) were established in the 2017 revised Ehlers-Danlos syndrome (EDS) nosology [<a class="bk_pop" href="#fkbp14-keds.REF.malfait.2017.8">Malfait et al 2017</a>]; see <a href="#fkbp14-keds.Establishing_the_Diagnosis">Establishing the Diagnosis</a>.</p><div id="fkbp14-keds.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>FKBP14</i> kyphoscoliotic Ehlers-Danlos syndrome (<i>FKBP14</i>-kEDS) <b>should be suspected</b> in individuals with kyphoscoliosis, severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscle hypotonia, and joint hypermobility</p><p>Major and minor clinical features of <i>FKBP14</i> kyphoscoliotic EDS have been outlined as follows (adapted from <a class="bk_pop" href="#fkbp14-keds.REF.malfait.2017.8">Malfait et al [2017]</a> and <a class="bk_pop" href="#fkbp14-keds.REF.giunta.b">Giunta et al [2018b]</a>).</p><p><b>Major clinical features</b></p><ul><li class="half_rhythm"><div>Congenital muscular hypotonia</div></li><li class="half_rhythm"><div>Congenital or early onset kyphoscoliosis</div></li><li class="half_rhythm"><div>Generalized joint hypermobility</div></li></ul><p><b>Gene-specific minor features</b></p><ul><li class="half_rhythm"><div>Early onset sensorineural, conductive or mixed hearing impairment (see <a href="#fkbp14-keds.Clinical_Description">Clinical Description</a>)</div></li><li class="half_rhythm"><div>Muscle atrophy</div></li><li class="half_rhythm"><div>Follicular hyperkeratosis</div></li><li class="half_rhythm"><div>Bladder diverticula</div></li></ul><p><b>Other suggestive findings</b></p><ul><li class="half_rhythm"><div>Marfanoid habitus</div></li><li class="half_rhythm"><div>Pectus deformity</div></li><li class="half_rhythm"><div>Talipes equinovarus</div></li><li class="half_rhythm"><div>Skin hyperextensibility</div></li><li class="half_rhythm"><div>Easily bruisable skin</div></li><li class="half_rhythm"><div>Hernia (umbilical or inguinal)</div></li><li class="half_rhythm"><div>Rupture/aneurysm of a medium-sized artery</div></li><li class="half_rhythm"><div>Blue sclerae</div></li><li class="half_rhythm"><div>Refractive errors (myopia, hypermetropia)</div></li><li class="half_rhythm"><div>Osteopenia/osteoporosis</div></li></ul><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div>Normal or only slightly elevated serum creatine kinase (CK) level</div></li><li class="half_rhythm"><div>Histopathology of muscle biopsies showing nonspecific mild myopathic changes with increased variation in muscle fiber diameter to more pronounced changes with profound fiber atrophy and proliferation of fatty tissue</div></li></ul><p>Note: At the moment, muscle biopsy is not required to make the diagnosis of <i>FKBP14</i>-kEDS.</p><p><b>Supportive imaging findings.</b> MRI of the lower limbs that may demonstrate fatty degeneration of multiple muscle groups, including rectus femoris and soleus</p></div><div id="fkbp14-keds.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>Proposed minimal clinical diagnostic criteria for <i>FKBP14</i>-kEDS include the following [<a class="bk_pop" href="#fkbp14-keds.REF.malfait.2017.8">Malfait et al 2017</a>]:</p><ul><li class="half_rhythm"><div>Congenital muscular hypotonia <b>AND</b> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or early-onset kyphoscoliosis; <b>PLUS</b></div></li><li class="half_rhythm"><div>Either or both of the following:</div><ul><li class="half_rhythm"><div>Generalized joint hypermobility</div></li><li class="half_rhythm"><div>Three minor criteria (from either <b>Gene-specific minor features</b> or <b>Other suggestive findings</b>)</div></li></ul></li></ul><p>However, the diagnosis of <i>FKBP14-</i>kEDS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FKBP14</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK541503/table/fkbp14-keds.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figfkbp14kedsTmoleculargenetictesting" rid-ob="figobfkbp14kedsTmoleculargenetictesting">Table 1</a>).</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>FKBP14</i>-kEDS is broad, individuals with the distinctive findings described in <a href="#fkbp14-keds.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#fkbp14-keds.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited generalized connective tissue disorders are more likely to be diagnosed using genomic testing (see <a href="#fkbp14-keds.Option_2">Option 2</a>).</p><div id="fkbp14-keds.Option_1"><h4>Option 1</h4><p>When the phenotypic findings suggest the diagnosis of <i>FKBP14</i>-kEDS <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is indicated. Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>FKBP14</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected.</div><div class="half_rhythm">Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div><div class="half_rhythm"><b>Note:</b> A common c.362dupC variant accounts for approximately 70% of disease alleles [<a class="bk_pop" href="#fkbp14-keds.REF.baumann.2012.201">Baumann et al 2012</a>, <a class="bk_pop" href="#fkbp14-keds.REF.giunta.b">Giunta et al 2018b</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A connective tissue disorder <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>FKBP14</i> and other genes of interest (see <a href="#fkbp14-keds.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div></li></ul><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="fkbp14-keds.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited connective tissue disorders, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is non-diagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="fkbp14-keds.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>FKBP14</i> Kyphoscoliotic Ehlers-Danlos Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541503/table/fkbp14-keds.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fkbp14-keds.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fkbp14-keds.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_fkbp14-keds.T.molecular_genetic_testing_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_fkbp14-keds.T.molecular_genetic_testing_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_fkbp14-keds.T.molecular_genetic_testing_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FKBP14</i></td><td headers="hd_h_fkbp14-keds.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_fkbp14-keds.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24/24&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_fkbp14-keds.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_fkbp14-keds.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fkbp14-keds.TF.1.1"><p class="no_margin">See <a href="/books/NBK541503/#fkbp14-keds.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="fkbp14-keds.TF.1.2"><p class="no_margin">See <a href="#fkbp14-keds.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="fkbp14-keds.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="fkbp14-keds.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#fkbp14-keds.REF.baumann.2012.201">Baumann et al [2012]</a>, <a class="bk_pop" href="#fkbp14-keds.REF.aldeeri.2014.469">Aldeeri et al [2014]</a>, <a class="bk_pop" href="#fkbp14-keds.REF.murray.2014.1750">Murray et al [2014]</a>, <a class="bk_pop" href="#fkbp14-keds.REF.dordoni.2016.2031">Dordoni et al [2016]</a>, <a class="bk_pop" href="#fkbp14-keds.REF.bursztejn.2017.64">Bursztejn et al [2017]</a>, <a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al [2018a]</a>, <a class="bk_pop" href="#fkbp14-keds.REF.castori.2019.317">Castori et al [2019]</a>. Note: The <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual published by <a class="bk_pop" href="#fkbp14-keds.REF.bursztejn.2017.64">Bursztejn et al [2017]</a> was initially published by <a class="bk_pop" href="#fkbp14-keds.REF.baumann.2012.201">Baumann et al [2012]</a>.</p></div></dd><dt>5. </dt><dd><div id="fkbp14-keds.TF.1.5"><p class="no_margin">A common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (c.362dupC) has been reported; see <a class="figpopup" href="/books/NBK541503/table/fkbp14-keds.T.notable_fkbp14_pathogenic/?report=objectonly" target="object" rid-figpopup="figfkbp14kedsTnotablefkbp14pathogenic" rid-ob="figobfkbp14kedsTnotablefkbp14pathogenic">Table 6</a>.</p></div></dd><dt>6. </dt><dd><div id="fkbp14-keds.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="fkbp14-keds.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div></div><div id="fkbp14-keds.Clinical_Characteristics"><h2 id="_fkbp14-keds_Clinical_Characteristics_">Clinical Characteristics</h2><div id="fkbp14-keds.Clinical_Description"><h3>Clinical Description</h3><p><i>FKBP14</i> kyphoscoliotic Ehlers-Danlos syndrome (<i>FKBP14</i>-kEDS) is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscle hypotonia and weakness that typically improves during childhood, progressive scoliosis, joint hypermobility, hyperelastic skin, gross motor developmental delay, myopathy, and hearing impairment [<a class="bk_pop" href="#fkbp14-keds.REF.baumann.2012.201">Baumann et al 2012</a>, <a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>]. Occasional features underlying systemic connective tissue involvement include aortic rupture and arterial dissection, subdural hygroma (potentially due to subdural bleeding or spontaneous intracranial hypotension), insufficiency of cardiac valves, bluish sclerae, bladder diverticula, inguinal or umbilical herniae, and premature rupture of membranes during pregnancy [<a class="bk_pop" href="#fkbp14-keds.REF.murray.2014.1750">Murray et al 2014</a>, <a class="bk_pop" href="#fkbp14-keds.REF.dordoni.2016.2031">Dordoni et al 2016</a>, <a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>].</p><p>A range of clinical severity is observed in individuals with <i>FKBP14</i>-kEDS for each of the systems discussed in this section [<a class="bk_pop" href="#fkbp14-keds.REF.baumann.2012.201">Baumann et al 2012</a>, <a class="bk_pop" href="#fkbp14-keds.REF.brady.2017.70">Brady et al 2017</a>, <a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>].</p><p><b>Prenatal.</b> Pregnancy involving an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus is often characterized by reduced fetal movements and an increased risk of premature rupture of membranes.</p><p><b>Muscular features.</b> Individuals with <i>FKBP14</i>-kEDS typically present at birth with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hypotonia and weakness. They often show feeding problems, and some will need airway management or respiratory support. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants have poor head control. With rare exceptions, motor developmental delay and reduced motor strength are common features in childhood, although muscle weakness typically improves during childhood [<a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>]. Most children achieve independent walking between ages two and four years. A decline of motor function in adulthood appears to represent an age-dependent feature in the natural course of this condition, but affected individuals are likely to be able to participate in activities of daily living in adulthood and maintain independent walking.</p><p>Wider phenotypic variability of the muscular features may exist, as suggested by the presence of early-onset muscle disease with severe involvement of the lower-limb muscles in one recently described <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual [<a class="bk_pop" href="#fkbp14-keds.REF.castori.2019.317">Castori et al 2019</a>].</p><p><b>Skeletal/joint features</b></p><ul><li class="half_rhythm"><div>Kyphoscoliosis is a hallmark of <i>FKBP14</i>-kEDS and is usually severe and progressive. Two thirds of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals manifest kyphoscoliosis before age one year (range: birth&#x02013;7 years in 15 affected individuals described by <a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al [2018a]</a>). Progressive kyphoscoliosis may respond to bracing, but often surgery is needed. Severe kyphoscoliosis may lead to restrictive lung disease without need for assisted ventilation.</div></li><li class="half_rhythm"><div>Pronounced joint hypermobility (mean value of Beighton score 8/9) is seen in 23/23 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>] for the small joints and 21/23 for the large joints. Joint hypermobility usually decreases with age.</div><ul><li class="half_rhythm"><div>Hypermobility may result in recurrent joint dislocations/sprains or chronic pain (5/23 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported).</div></li><li class="half_rhythm"><div>Foot deformities that include <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or postural talipes and <i>pes planus</i> / <i>planovalgus</i> have been found in 23/23 of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li></ul></li><li class="half_rhythm"><div>Despite significant joint hypermobility, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> contractures are present in up to one third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and may impact the fingers, wrist, elbows, or knees (7/23). Congenital hip dislocation is present in 4/17 of affected individuals.</div></li><li class="half_rhythm"><div>Fractures probably due to osteopenia/osteoporosis from immobility occurred in 3/23.</div></li><li class="half_rhythm"><div>Atlantoaxial subluxation/instability has been reported in three individuals [<a class="bk_pop" href="#fkbp14-keds.REF.dordoni.2016.2031">Dordoni et al 2016</a>, <a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>, <a class="bk_pop" href="#fkbp14-keds.REF.castori.2019.317">Castori et al 2019</a>].</div></li></ul><p><b>Eyes.</b> Refractive errors, myopia, and hypermetropia are moderately frequent, present in about two thirds of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Blue sclerae are present in about one third of affected individuals.</p><p><b>Ears.</b> Hearing impairment can manifest at birth, in early infancy, or even later in life [<a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>]. Sensorineural hearing impairment is the most frequent, present in about half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; conductive hearing loss is present in up to one quarter. Hearing impairment (either conductive or sensorineural) may manifest later in life or remain subclinical, thus necessitating periodic investigations (see <a href="#fkbp14-keds.Management">Management</a>).</p><p><b>Cardiovascular.</b> Vascular complications in adulthood and their possible occurrence in childhood suggests that cardiovascular investigations in the routine assessment and follow up of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is indicated (see <a href="#fkbp14-keds.Management">Management</a>). Cardiovascular complications can be <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> (septal defects in a minority) or acquired (usually mild mitral or pulmonary valve insufficiency or dilatation of the ascending aorta).</p><p>Additionally, artery dissections occurred in two adult individuals (internal carotid artery and celiac artery) [<a class="bk_pop" href="#fkbp14-keds.REF.murray.2014.1750">Murray et al 2014</a>, <a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>] and a pseudoaneurysm rupture occurred in one child (hypogastric artery) [<a class="bk_pop" href="#fkbp14-keds.REF.dordoni.2016.2031">Dordoni et al 2016</a>].</p><p><b>Skin and integument.</b> All individuals described to date have had a subjective finding of soft skin texture. Hyperextensibility was found in 17/23. Atrophic and hypertrophic scarring are seen in fewer than half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, as is easy bruising. Additional findings may include follicular hyperkeratosis and crisscross palms/soles.</p><p><b>Other findings</b></p><ul><li class="half_rhythm"><div>Inguinal and/or umbilical hernia in about half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (11/23), sometimes with redundant umbilical skin.</div></li><li class="half_rhythm"><div>Bifid uvula with submucous cleft palate or frank cleft palate (7/23)</div></li><li class="half_rhythm"><div>Speech or language delay (7/20); true intellectual disability is rare and may be unrelated in children of <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> relationships.</div></li><li class="half_rhythm"><div>Visceral complications, including large bladder diverticula (3/19) and (rarely) rectal prolapse.</div></li></ul><p><b>Prognosis.</b> It is unknown if life span in individuals with <i>FKBP14-</i>kEDS is reduced. One reported individual is alive at age 53 years [<a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>], demonstrating that survival into adulthood is possible. Since many adults with disabilities have not undergone advanced genetic testing, it is likely that adults with this condition are underrecognized and underreported.</p></div><div id="fkbp14-keds.GenotypePhenotype_Correlatio"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations that predict risk for specific complications or clinical severity have not been reported to date.</p></div><div id="fkbp14-keds.Pathophysiology"><h3>Pathophysiology</h3><p>The pathomechanism of <i>FKBP14</i>-kEDS is only partially understood [<a class="bk_pop" href="#fkbp14-keds.REF.baumann.2012.201">Baumann et al 2012</a>]. Pathology findings include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Normal collagen biosynthesis and secretion of collagen types I, III, and V</div></li><li class="half_rhythm"><div class="half_rhythm">Disarray of the main components of the extracellular matrix (i.e., collagen type I, III, and VI; fibronectin; tenascins; thrombospondin) by indirect immunofluorescence on skin fibroblast from <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div><div class="half_rhythm">Type V collagen is organized in an extracellular network that is similar to control fibroblasts.</div></li><li class="half_rhythm"><div class="half_rhythm">Loss of the main receptors of collagens and fibronectin, &#x003b1;2&#x003b2;1 and &#x003b1;5&#x003b2;1 integrins.</div></li><li class="half_rhythm"><div class="half_rhythm">Marked enlargement of the ER cisterns with accumulation of flocculent material in skin cells of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals by transmission electron microscopy</div></li></ul><p>See also <a href="#fkbp14-keds.Molecular_Pathogenesis">Molecular Pathogenesis</a>.</p></div><div id="fkbp14-keds.Nomenclature"><h3>Nomenclature</h3><p><i>FKBP14-</i>kEDS was initially referred to as a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. Since the development of the 2017 EDS Nosology [<a class="bk_pop" href="#fkbp14-keds.REF.malfait.2017.8">Malfait et al 2017</a>], it is known as kEDS-<i>FKBP14, FKBP14-</i>kEDS, and <i>FKBP14</i>-related kEDS<i>.</i></p></div><div id="fkbp14-keds.Prevalence"><h3>Prevalence</h3><p><i>FKBP14</i>-kEDS is rare; the exact prevalence is unknown. From its first description in 2012, 30 individuals are known to the Authors at the time of review (2019). A disease incidence of approximately 1:100,000 live births is a reasonable estimate. Prevalence does not vary by race or ethnicity.</p></div></div><div id="fkbp14-keds.Genetically_Related_Allelic"><h2 id="_fkbp14-keds_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>FKBP14</i>.</p></div><div id="fkbp14-keds.Differential_Diagnosis"><h2 id="_fkbp14-keds_Differential_Diagnosis_">Differential Diagnosis</h2><div id="fkbp14-keds.T.disorders_to_consider_in_t" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of <i>FKBP14</i> Kyphoscoliotic Ehlers-Danlos Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541503/table/fkbp14-keds.T.disorders_to_consider_in_t/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fkbp14-keds.T.disorders_to_consider_in_t_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_1" style="text-align:left;vertical-align:middle;">Differential Diagnosis Disorder</th><th id="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4" id="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/<i>FKBP14</i>-kEDS</th><th headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4" id="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from <i>FKBP14</i>-kEDS</th></tr></thead><tbody><tr><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/eds6/"><i>PLOD1</i> kyphoscoliotic EDS</a></td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLOD1</i></td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4 hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital muscular hypotonia</div></li><li class="half_rhythm"><div>Congenital/early onset kyphoscoliosis</div></li><li class="half_rhythm"><div>Generalized joint hypermobility</div></li></ul>
</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4 hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Absence of hearing impairment</div></li><li class="half_rhythm"><div>&#x02191; ratio of urinary pyridinolines</div></li></ul>
</td></tr><tr><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Musculocontractural EDS<br />(OMIM <a href="https://omim.org/entry/601776" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601776</a>, <a href="https://omim.org/entry/615539" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615539</a>)</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHST14</i><br /><i>DSE</i></td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4 hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Joint hypermobility</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4 hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Characteristic craniofacial features</div></li><li class="half_rhythm"><div>Peculiar fingers (tapering, slender, cylindric)</div></li></ul>
</td></tr><tr><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bethlem/">Collagen type VI-related disorders</a></td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL6A1</i><br /><i>COL6A2</i><br /><i>COL6A3</i></td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4 hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital muscular hypotonia</div></li><li class="half_rhythm"><div>Progressive kyphoscoliosis</div></li><li class="half_rhythm"><div>Joint hypermobility</div></li><li class="half_rhythm"><div>Follicular hyperkeratosis</div></li></ul>
</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4 hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Myopathy on muscle biopsy&#x000a0;<b><sup>1</sup></b></div></li><li class="half_rhythm"><div>Respiratory muscle failure</div></li><li class="half_rhythm"><div>Absence of skin hyperelasticity &#x00026; easy bruising</div></li><li class="half_rhythm"><div>Absence of hearing impairment &#x00026; cardiovascular problems</div></li></ul>
</td></tr><tr><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spondylodysplastic EDS (spEDS)<br />(OMIM <a href="https://omim.org/entry/130070" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">130070</a>, <a href="https://omim.org/entry/612350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">612350</a>, <a href="https://omim.org/entry/615349" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615349</a>)</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>B4GALT7</i><br /><i>B3GALT6</i><br /><i>SLC39A13</i></td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4 hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital muscular hypotonia</div></li><li class="half_rhythm"><div>Kyphoscoliosis (<i>B3GALT6</i>-spEDS)</div></li><li class="half_rhythm"><div>Joint hypermobility</div></li><li class="half_rhythm"><div>Pectus deformities</div></li></ul>
</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4 hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive short stature</div></li><li class="half_rhythm"><div>Primary skeletal involvement</div></li><li class="half_rhythm"><div>Dysplastic teeth</div></li></ul>
</td></tr><tr><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myopathic EDS<br />(OMIM <a href="https://omim.org/entry/616471" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616471</a>)</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL12A1</i></td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4 hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital muscular hypotonia</div></li><li class="half_rhythm"><div>Motor developmental delay</div></li><li class="half_rhythm"><div>Soft, doughy skin</div></li><li class="half_rhythm"><div>Muscular atrophy</div></li></ul>
</td><td headers="hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_1_4 hd_h_fkbp14-keds.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Myopathy on muscle biopsy&#x000a0;<b><sup>1</sup></b></div></li><li class="half_rhythm"><div>Severe progressive scoliosis</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; EDS = Ehlers-Danlos syndrome; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="fkbp14-keds.TF.2.1"><p class="no_margin">In Bethlem myopathy, muscle biopsies reveal myopathic or dystrophic changes. Collagen VI immunolabeling is often normal or shows only subtle alterations. Conversely, in Ulrich <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy muscle biopsies more commonly show dystrophic features with degeneration and regeneration and replacement of muscle with fat and fibrous connective tissue. Collagen VI immunolabeling from the endomysium and basal lamina ranges from absent to moderately or markedly reduced, but may be normal around the capillaries (see <a href="/books/n/gene/bethlem/">Collagen Type VI-Related Disorders</a>).</p></div></dd></dl></div></div></div></div><div id="fkbp14-keds.Management"><h2 id="_fkbp14-keds_Management_">Management</h2><div id="fkbp14-keds.Evaluations_Following_Initia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>FKBP14</i> kyphoscoliotic Ehlers-Danlos syndrome (<i>FKBP14-</i>kEDS), the evaluations summarized in <a class="figpopup" href="/books/NBK541503/table/fkbp14-keds.T.recommended_evaluations_fo/?report=objectonly" target="object" rid-figpopup="figfkbp14kedsTrecommendedevaluationsfo" rid-ob="figobfkbp14kedsTrecommendedevaluationsfo">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="fkbp14-keds.T.recommended_evaluations_fo" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with <i>FKBP14-</i>kEDS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541503/table/fkbp14-keds.T.recommended_evaluations_fo/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fkbp14-keds.T.recommended_evaluations_fo_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Clinical &#x00026; radiologic documentation of kyphoscoliosis &#x00026; measurement of curvature</div></li><li class="half_rhythm"><div>Evaluation for joint contractures &#x00026; other skeletal features&#x000a0;<sup>1</sup></div></li></ul>
</td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to orthopedist</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Physical therapy evaluation</td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To develop a specific program to be followed by patient</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Dual-energy X-ray absorptiometry (DEXA)</td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In those w/frequent fractures or decreased ambulation</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for refractive errors</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ears</b></td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiology evaluation</td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">A repeat hearing evaluation is recommended even if patient had normal newborn hearing screen.</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Echocardiography</td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>To include measurement of aortic root size and assessment of heart valves</div></li><li class="half_rhythm"><div>Cardiac &#x00026; abdominal ultrasound /MRI may also be considered to monitor for aortic dilatation.</div></li></ul>
</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Measurement of blood pressure</td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Maintenance of blood pressure in normal range for age recommended to reduce risk of arterial rupture</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Craniofacial</b></td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of the palate for submucous or frank cleft</td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to craniofacial clinic if palatal anomalies are suspected</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To include motor, speech/language evaluation, general cognitive, &#x00026; vocational skills</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_fkbp14-keds.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fkbp14-keds.TF.3.1"><p class="no_margin">Care providers should be made aware of the possibility of atlantoaxial instability; however, proactive assessment for this finding is not typically done.</p></div></dd></dl></div></div></div></div><div id="fkbp14-keds.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="fkbp14-keds.T.treatment_of_manifestation" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with <i>FKBP14-</i>kEDS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541503/table/fkbp14-keds.T.treatment_of_manifestation/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fkbp14-keds.T.treatment_of_manifestation_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Severe scoliosis</b></td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment, ideally in multidisciplinary setting</td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Surgery may be indicated for severe scoliosis.</div></li><li class="half_rhythm"><div>At surgery caution should be taken due to risk for vascular complications, atlantoaxial instability, &#x00026; primary muscle disease.</div></li></ul>
</td></tr><tr><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Clubbed foot/</b><br /><b>Foot deformity</b></td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment, ideally in multidisciplinary setting</td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orthopedic shoe insoles may be beneficial for those w/foot deformity &#x00026; joint instability</td></tr><tr><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Osteopenia/</b><br /><b>Osteoporosis</b></td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment</td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Age-dependent muscle decline</b></td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physiotherapy program</td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Orthopedists, rehabilitation medicine, &#x00026; physical &#x00026; occupational therapists can assist in recommending appropriate devices to improve joint stability.</div></li><li class="half_rhythm"><div>Walker or wheelchair may be necessary for mobility.</div></li></ul>
</td></tr><tr><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ocular refraction abnormality</b></td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment(s) as recommended by ophthalmologist</td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing impairment</b></td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment, which may include use of hearing aid</td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>.</td></tr><tr><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Aortic dilation/</b><br /><b>Vascular dissection</b></td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Eventually, use of beta blockers in patients with aortic dilation to prevent further expansion</td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Use of beta blockers (e.g., celiprolol) may be considered based on their efficiency in vascular EDS.&#x000a0;<sup>1</sup></div></li><li class="half_rhythm"><div>Vascular surgery is extremely risky because of vascular fragility in EDS.</div></li></ul>
</td></tr><tr><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cleft palate</b></td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment</td><td headers="hd_h_fkbp14-keds.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fkbp14-keds.TF.4.1"><p class="no_margin"><a class="bk_pop" href="#fkbp14-keds.REF.ong.2010.1476">Ong et al [2010]</a></p></div></dd></dl></div></div></div><div id="fkbp14-keds.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility.</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy (typically from an occupational or speech therapist) is recommended for individuals who have difficulty feeding due to poor oral motor control.</p></div></div><div id="fkbp14-keds.Surveillance"><h3>Surveillance</h3><p>Standardized medical surveillance guidelines for individuals with <i>FKBP14</i>-kEDS have not been published.</p><div id="fkbp14-keds.T.recommended_surveillance_f" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with <i>FKBP14-</i>kEDS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541503/table/fkbp14-keds.T.recommended_surveillance_f/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fkbp14-keds.T.recommended_surveillance_f_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluations by orthopedic physician &#x00026; specialist in rehabilitation medicine for managementof kyphoscoliosis, contractures, &#x00026; foot deformities</td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As clinically indicated but at least annually</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">DEXA scan</td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 2-5 yrs, or in those w/reduced ambulation</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine ophthalmologic evaluation</td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 2-3 years</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ears</b></td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Formal hearing evaluation</td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 2-3 years</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Blood pressure measurement&#x000a0;<sup>1</sup></td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Echocardiography w/consideration of cardiac MRI</div></li><li class="half_rhythm"><div>Vascular ultrasonography to evaluate abdominal &#x00026;peripheral arteries &#x00026; veins</div></li></ul>
</td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 2-5 yrs starting in early childhood</td></tr><tr><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurodevelopment</b></td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of developmental progress</td><td headers="hd_h_fkbp14-keds.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit until adolescence</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fkbp14-keds.TF.5.1"><p class="no_margin">Maintenance of blood pressure in the normal range for age is recommended to reduce the risk of arterial rupture.</p></div></dd></dl></div></div></div></div><div id="fkbp14-keds.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>For children with severe joint hypermobility, sports that place stress on the joints</div></li><li class="half_rhythm"><div>High blood pressure</div></li><li class="half_rhythm"><div>For individuals with aortic aneurysm, contact sports</div></li></ul></div><div id="fkbp14-keds.Evaluation_of_Relatives_at_R"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from prompt initiation of treatment and surveillance measures. Molecular genetic testing can be used if the pathogenic variants in the family are known.</p><p>See <a href="#fkbp14-keds.Related_Genetic_Counseling_I">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="fkbp14-keds.Pregnancy_Management"><h3>Pregnancy Management</h3><p>No pregnancies in women with <i>FKBP14</i>-kEDS have been reported to date. An increased risk for miscarriage, premature rupture of membranes, and rupture of arteries in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> pregnant women should be considered. Delivery in a medical center with a high-risk perinatologist in attendance is recommended.</p></div><div id="fkbp14-keds.Therapies_Under_Investigatio"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="fkbp14-keds.Genetic_Counseling"><h2 id="_fkbp14-keds_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="fkbp14-keds.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>FKBP14</i> kyphoscoliotic Ehlers-Danlos syndrome (<i>FKBP14-</i>kEDS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>FKBP14</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with <i>FKBP14-</i>kEDS are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FKBP14</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>FKBP14</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="fkbp14-keds.Carrier_Heterozygote_Detecti"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>FKBP14</i> pathogenic variants in the family.</p></div><div id="fkbp14-keds.Related_Genetic_Counseling_I"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#fkbp14-keds.Evaluation_of_Relatives_at_R">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="fkbp14-keds.Prenatal_Testing_and_Preimpl"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>FKBP14</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="fkbp14-keds.Resources"><h2 id="_fkbp14-keds_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Association Francaise des Syndrome d'Ehlers Danlos (AFSED)</b></div><div>67, rue Jules Lecesne</div><div>Le Havre 76600</div><div>France</div><div><b>Phone:</b> 0820 20 37 33</div><div><b>Email:</b> contact@afsed.com</div><div><a href="http://afsed.fr/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.afsed.fr</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Society - Europe</b></div><div>35-37 Ludgate Hill</div><div>Office 7</div><div>London EC4M 7JN</div><div>United Kingdom</div><div><b>Phone:</b> +44 203 887 6132</div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Society Headquarters</b></div><div>P.O. Box 87463</div><div>Montgomery Village MD 20886</div><div><b>Phone:</b> 410-670-7577</div><div><b>Email:</b> info@ehlers-danlos.com</div><div><a href="https://ehlers-danlos.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.com</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Support Group</b></div><div>PO Box 337</div><div>Aldershot Surrey GU12 6WZ</div><div>United Kingdom</div><div><b>Phone:</b> 01252 690940</div><div><b>Email:</b> director@ehlers-danlos.org</div><div><a href="http://www.ehlers-danlos.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.org</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Support UK</b></div><div>PO Box 748</div><div>Borehamwood WD6 9HU</div><div>United Kingdom</div><div><b>Phone:</b> 0208 736 5604; 0800 9078518</div><div><a href="https://www.ehlers-danlos.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ehlersdanlossyndrome.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ehlers-Danlos Syndrome</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=ehlersdanlossyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ehlers-Danlos syndrome</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Society EDS &#x00026; Related Disorders Global Registry</b></div><div><a href="https://www.ehlers-danlos.com/eds-global-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.com/eds-global-registry</a></div></li></ul></div><div id="fkbp14-keds.Molecular_Genetics"><h2 id="_fkbp14-keds_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="fkbp14-keds.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541503/table/fkbp14-keds.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fkbp14-keds.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_fkbp14-keds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_fkbp14-keds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_fkbp14-keds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_fkbp14-keds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_fkbp14-keds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_fkbp14-keds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_fkbp14-keds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55033" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FKBP14</i></a></td><td headers="hd_b_fkbp14-keds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55033" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7p14<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_fkbp14-keds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NWM8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peptidyl-prolyl cis-trans isomerase FKBP14</a></td><td headers="hd_b_fkbp14-keds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FKBP14" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FKBP14 homepage - FKBP14 @ LOVD</a></td><td headers="hd_b_fkbp14-keds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FKBP14" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FKBP14</a></td><td headers="hd_b_fkbp14-keds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FKBP14[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FKBP14</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="fkbp14-keds.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="fkbp14-keds.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome (<a href="/omim/614505,614557" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541503/table/fkbp14-keds.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fkbp14-keds.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614505" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614505</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FK506-BINDING PROTEIN 14; FKBP14</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614557" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614557</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2</td></tr></tbody></table></div></div><div id="fkbp14-keds.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>FKBP14</i> (transcript variant 1) encodes a 211-amino acid FKBP22 (alias FKBP14) protein, which contains a signal peptide of 18 residues and forms a dimer of identical subunits [<a class="bk_pop" href="#fkbp14-keds.REF.boudko.2014.67">Boudko et al 2014</a>]. The protein consists of three domains:</p><ul><li class="half_rhythm"><div>The PPIase catalytic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (aa 45-135)</div></li><li class="half_rhythm"><div>The first EF-hand1 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (aa 135-170)</div></li><li class="half_rhythm"><div>The second EF-hand2 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (aa 179-211)</div></li></ul><p>FKBP22 is an ER resident protein that belongs to the FK506-binding protein (FKBP) class of immunophilins, which have been implicated in catalyzing cis-trans-isomerization of peptidyl-prolyl peptide bonds and are supposed to accelerate protein folding. FKBP22 catalyzes the folding of type III collagen and interacts with type III collagen, type VI collagen, and type X collagen, but not with type I collagen, type II collagen, or type V collagen [<a class="bk_pop" href="#fkbp14-keds.REF.ishikawa.2014.18189">Ishikawa &#x00026; B&#x000e4;chinger 2014</a>]. Remarkably, pathogenic variants in type III and type VI collagens cause the vascular type of EDS (vEDS) and <i>COL6</i>-related muscular dystrophies, respectively. Therefore, the clinical features of vascular abnormalities and myopathy documented in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals clearly correlates with the interaction of FKBP14 with type III and VI collagens [<a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>] (see also <a href="#fkbp14-keds.Pathophysiology">Pathophysiology</a>).</p><p><b>Mechanism of disease causation.</b> The majority of <i>FKBP14</i> pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants [<a class="bk_pop" href="#fkbp14-keds.REF.baumann.2012.201">Baumann et al 2012</a>, <a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>]. The common c.362dupC frameshift, which is found with a frequency of approximately 70%, is the most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#fkbp14-keds.REF.baumann.2012.201">Baumann et al 2012</a>, <a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>] and has been linked to the same haplotype in all individuals tested [<a class="bk_pop" href="#fkbp14-keds.REF.murray.2014.1750">Murray et al 2014</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant, p.Met48Lys [<a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>], and an <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, p.Glu191del [<a class="bk_pop" href="#fkbp14-keds.REF.dordoni.2016.2031">Dordoni et al 2016</a>], have also been reported. Mapping of the missense variant p.Met48Lys onto the protein crystal structure near the potential PPIase active site of FKBP22 supports complete or partial loss of function of <i>FKBP14</i> as a further disease mechanism in addition to loss of protein [<a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>].</p><p>Western blot analysis using a FKBP14 mouse polyclonal antibody showed deficiency of FKBP14 in two individuals with <i>FKBP14</i>-kEDS [<a class="bk_pop" href="#fkbp14-keds.REF.baumann.2012.201">Baumann et al 2012</a>].</p><p><b><i>FKBP14</i>-specific laboratory technical considerations.</b>
<i>FKBP14</i> consists of three small exons, a rather large fourth <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>, which includes the 3' UTR, and three rather large introns. Transcript variants 2 and 3 are noncoding.</p><div id="fkbp14-keds.T.notable_fkbp14_pathogenic" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Notable <i>FKBP14</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541503/table/fkbp14-keds.T.notable_fkbp14_pathogenic/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fkbp14-keds.T.notable_fkbp14_pathogenic_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_017946.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_017946<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_060416.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_060416<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.573_575del</td><td headers="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu191del</td><td headers="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Only <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> variant reported [<a class="bk_pop" href="#fkbp14-keds.REF.dordoni.2016.2031">Dordoni et al 2016</a>]</td></tr><tr><td headers="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.362dupC</td><td headers="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu122ArgfsTer7</td><td headers="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#fkbp14-keds.REF.baumann.2012.201">Baumann et al 2012</a>, <a class="bk_pop" href="#fkbp14-keds.REF.dordoni.2016.2031">Dordoni et al 2016</a>, <a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>, <a class="bk_pop" href="#fkbp14-keds.REF.castori.2019.317">Castori et al 2019</a>]</td></tr><tr><td headers="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.143T&#x0003e;A</td><td headers="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met48Lys</td><td headers="hd_h_fkbp14-keds.T.notable_fkbp14_pathogenic_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Missense change reported near PPIase active site [<a class="bk_pop" href="#fkbp14-keds.REF.giunta.2018a.42">Giunta et al 2018a</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div></div></div><div id="fkbp14-keds.References"><h2 id="_fkbp14-keds_References_">References</h2><div id="fkbp14-keds.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.aldeeri.2014.469">Aldeeri AA, Alazami AM, Hijazi H, Alzahrani F, Alkuraya FS. Excessively redundant umbilical skin as a potential early clinical feature of Morquio syndrome and FKBP14-related Ehlers-Danlos syndrome. <span><span class="ref-journal">Clin Genet. </span>2014;<span class="ref-vol">86</span>:469–72.</span> [<a href="/pubmed/24773188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24773188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.baumann.2012.201">Baumann M, Giunta C, Krabichler B, R&#x000fc;schendorf F, Zoppi N, Colombi M, Bittner RE, Quijano-Roy S, Muntoni F, Cirak S, Schreiber G, Zou Y, Hu Y, Romero NB, Carlier RY, Amberger A, Deutschmann A, Straub V, Rohrbach M, Steinmann B, Rost&#x000e1;sy K, Karall D, B&#x000f6;nnemann CG, Zschocke J, Fauth C. Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy and hearing loss. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:201–16.</span> [<a href="/pmc/articles/PMC3276673/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3276673</span></a>] [<a href="/pubmed/22265013" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22265013</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.boudko.2014.67">Boudko SP, Ishikawa Y, Nix J, Chapman MS, Bachinger HP. Structure of human peptidyl-prolyl cis-trans isomerase FKBP22 containing two EF-hand motifs. <span><span class="ref-journal">Protein Sci. </span>2014;<span class="ref-vol">23</span>:67–75.</span> [<a href="/pmc/articles/PMC3892300/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3892300</span></a>] [<a href="/pubmed/24272907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24272907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.brady.2017.70">Brady AF, Demirdas S, Fournel-Gigleux S, Ghali N, Giunta C, Kapferer-Seebacher I, Kosho T, Mendoza-Londono R, Pope MF, Rohrbach M, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Zschocke J, Malfait F. The Ehlers-Danlos syndromes, rare types. <span><span class="ref-journal">Am J Med Genet Part C Semin Med Genet. </span>2017;<span class="ref-vol">175</span>:70–115.</span> [<a href="/pubmed/28306225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28306225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.bursztejn.2017.64">Bursztejn AC, Baumann M, Lipsker D. Ehlers&#x02013;Danlos syndrome related to FKBP14 mutations: detailed cutaneous phenotype. <span><span class="ref-journal">Clin Exp. Dermatol. </span>2017;<span class="ref-vol">42</span>:64–7.</span> [<a href="/pubmed/27905128" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27905128</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.castori.2019.317">Castori M, Fiorillo C, Agolini E, Sacco M, Minetti C, Novelli A, Guglielmi G, Bertini E. Primary muscle involvement in a 15-year-old girl with the recurrent homozygous c.362dupC variant in FKBP14. <span><span class="ref-journal">Am J Med Genet A. </span>2019;<span class="ref-vol">179</span>:317–21.</span> [<a href="/pubmed/30561154" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30561154</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.dordoni.2016.2031">Dordoni C, Ciaccio C, Venturini M, Calzavara-Pinton P, Ritelli M, Colombi M. Further delineation of FKBP14-related Ehlers-Danlos syndrome: A patient with early vascular complications and non-progressive kyphoscoliosis, and literature review. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:2031–8.</span> [<a href="/pubmed/27149304" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27149304</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.giunta.2018a.42">Giunta C, Baumann M, Fauth C, Lindert U, Abdalla EM, Brady AF, Collins J, Dastgir J, Donkervoort S, Ghali N, Johnson DS, Kariminejad A, Koch J, Kraenzlin M, Lahiri N, Lozic B, Manzur AY, Morton JEV, Pilch J, Pollitt RC, Schreiber G, Shannon NL, Sobey G, Vandersteen A, van Dijk FS, Witsch-Baumgartner M, Zschocke J, Pope FM, B&#x000f6;nnemann CG, Rohrbach M. A cohort of 17 patients with kyphoscoliotic Ehlers-Danlos syndrome caused by biallelic mutations in FKBP14: expansion of the clinical and mutational spectrum and description of the natural history. <span><span class="ref-journal">Genet Med. </span>2018a;<span class="ref-vol">20</span>:42–54.</span> [<a href="/pmc/articles/PMC5763155/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5763155</span></a>] [<a href="/pubmed/28617417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28617417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.giunta.b">Giunta C, Yeowell HN, Steinmann B. Kyphoscoliotic, arthrochalasia and dermatosparaxis Ehlers-Danlos Syndrome. In: Jacobs JWG, Cornelissens LJM, Veenhuizen MC, Hamel BCJ, eds. <em>Ehlers-Danlos syndrome: a multidisciplinary approach.</em> Amsterdam: IOS Press; 2018b:97-125. Available <a href="http://ebooks.iospress.nl/book/ehlers-danlos-syndrome-a-multidisciplinary-approach" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>.</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.ishikawa.2014.18189">Ishikawa Y, B&#x000e4;chinger HP. A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis. <span><span class="ref-journal">J Biol Chem. </span>2014;<span class="ref-vol">289</span>:18189–201.</span> [<a href="/pmc/articles/PMC4140264/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4140264</span></a>] [<a href="/pubmed/24821723" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24821723</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.malfait.2017.8">Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, De Backer J, De Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GJ, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B. The 2017 International classification of the Ehlers-Danlos syndromes. <span><span class="ref-journal">Am J Med Genet Part C Semin Med Genet. </span>2017;<span class="ref-vol">175</span>:8–26.</span> [<a href="/pubmed/28306229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28306229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.murray.2014.1750">Murray ML, Yang M, Fauth C, Byers PH. FKBP14-related Ehlers-Danlos syndrome: expansion of the phenotype to include vascular complications. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:1750–5.</span> [<a href="/pubmed/24677762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24677762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fkbp14-keds.REF.ong.2010.1476">Ong KT, Perdu J, De Backer J, Bozec E, Collignon P, Emmerich J, Fauret AL, Fiessinger JN, Germain DP, Georgesco G, Hulot JS, De Paepe A, Plauchu H, Jeunemaitre X, Laurent S, Boutouyrie P. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. <span><span class="ref-journal">Lancet. </span>2010;<span class="ref-vol">376</span>:1476–84.</span> [<a href="/pubmed/20825986" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20825986</span></a>]</div></li></ul></div></div><div id="fkbp14-keds.Chapter_Notes"><h2 id="_fkbp14-keds_Chapter_Notes_">Chapter Notes</h2><div id="fkbp14-keds.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>23 May 2019 (ma) Review posted live</div></li><li class="half_rhythm"><div>5 October 2018 (cg) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK541503</span><span class="label">PMID: <a href="/pubmed/31132235" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31132235</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/craniosynostosis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/x-pvh/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK541503&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK541503/?report=reader">PubReader</a></li><li><a href="/books/NBK541503/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK541503" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK541503" style="display:none" title="Cite this Page"><div class="bk_tt">Giunta C, Rohrbach M, Fauth C, et al. FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome. 2019 May 23. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK541503/pdf/Bookshelf_NBK541503.pdf">PDF version of this page</a> (468K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#fkbp14-keds.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#fkbp14-keds.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#fkbp14-keds.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#fkbp14-keds.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#fkbp14-keds.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#fkbp14-keds.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#fkbp14-keds.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#fkbp14-keds.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#fkbp14-keds.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#fkbp14-keds.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#fkbp14-keds.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55033[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FKBP14</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4772800" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4772800" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4772800" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4772800" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301635" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLOD1</i>-Related Kyphoscoliotic Ehlers-Danlos Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLOD1</i>-Related Kyphoscoliotic Ehlers-Danlos Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yeowell HN, Steinmann B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31288483" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Transcriptome Profiling of Primary Skin Fibroblasts Reveal Distinct Molecular Features Between &lt;i&gt;PLOD1&lt;/i&gt;- and &lt;i&gt;FKBP14&lt;/i&gt;-Kyphoscoliotic Ehlers-Danlos Syndrome.</a><span class="source">[Genes (Basel). 2019]</span><div class="brieflinkpop offscreen_noflow">Transcriptome Profiling of Primary Skin Fibroblasts Reveal Distinct Molecular Features Between &lt;i&gt;PLOD1&lt;/i&gt;- and &lt;i&gt;FKBP14&lt;/i&gt;-Kyphoscoliotic Ehlers-Danlos Syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lim PJ, Lindert U, Opitz L, Hausser I, Rohrbach M, Giunta C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Genes (Basel). 2019 Jul 8; 10(7). Epub 2019 Jul 8.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31063316" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">FKBP14 kyphoscoliotic Ehlers-Danlos Syndrome in adolescent patient: the first Colombian report.</a><span class="source">[Arch Argent Pediatr. 2019]</span><div class="brieflinkpop offscreen_noflow">FKBP14 kyphoscoliotic Ehlers-Danlos Syndrome in adolescent patient: the first Colombian report.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ruiz-Botero F, Ramírez-Montaño D, Pachajoa H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Arch Argent Pediatr. 2019 Jun 1; 117(3):e274-e278. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22265013" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss.</a><span class="source">[Am J Hum Genet. 2012]</span><div class="brieflinkpop offscreen_noflow">Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Baumann M, Giunta C, Krabichler B, Rüschendorf F, Zoppi N, Colombi M, Bittner RE, Quijano-Roy S, Muntoni F, Cirak S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2012 Feb 10; 90(2):201-16. Epub 2012 Jan 19.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31132235" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31132235" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0413b0dde0891169c36da8">FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:58:08-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D7293E0404AD1000000000653022C&amp;ncbi_session=CE8D7293E0413B01_1619SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK541503%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK541503&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK541503/&amp;ncbi_pagename=FKBP14 Kyphoscoliotic Ehlers-Danlos Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D7293E0413B01_1619SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>